Filing Details
- Accession Number:
- 0001140361-18-019522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-25 15:32:33
- Reporting Period:
- 2018-04-23
- Accepted Time:
- 2018-04-25 15:32:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 70487 | National Research Corp | NRCI | Services-Commercial Physical & Biological Research (8731) | 470634000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1053133 | D. Michael Hays | C/O National Research Corporation 1245 &Quot;Q&Quot; Street Lincoln NE 68508 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-04-23 | 80 | $35.00 | 0 | No | 4 | S | Indirect | By Spouse & Daughter Jt |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Spouse & Daughter Jt |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,071 | Direct | |
| Common Stock | 139,095 | Indirect | By Spouse |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | $8.12 | 2019-01-05 | 20,109 | 20,109 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $6.29 | 2020-01-05 | 26,481 | 26,481 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $9.14 | 2021-01-05 | 17,745 | 17,745 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $10.75 | 2022-01-05 | 14,949 | 14,949 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $14.50 | 2023-01-07 | 10,938 | 10,938 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $18.80 | 2024-01-07 | 2,904 | 2,904 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $13.17 | 2025-01-06 | 10,014 | 10,014 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $15.23 | 2026-01-05 | 9,145 | 9,145 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $18.80 | 2027-01-04 | 7,478 | 7,478 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $36.80 | 2028-01-03 | 5,193 | 5,193 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-01-05 | 20,109 | 20,109 | Direct |
| 2020-01-05 | 26,481 | 26,481 | Direct |
| 2021-01-05 | 17,745 | 17,745 | Direct |
| 2022-01-05 | 14,949 | 14,949 | Direct |
| 2023-01-07 | 10,938 | 10,938 | Direct |
| 2024-01-07 | 2,904 | 2,904 | Direct |
| 2025-01-06 | 10,014 | 10,014 | Direct |
| 2026-01-05 | 9,145 | 9,145 | Direct |
| 2027-01-04 | 7,478 | 7,478 | Direct |
| 2028-01-03 | 5,193 | 5,193 | Direct |
Footnotes
- The reporting person disclaims beneficial ownership of these shares.
- This option became fully exercisable on January 5, 2014.
- This option became fully exercisable on January 5, 2015.
- This option became fully exercisable on January 5, 2016.
- This option became fully exercisable on January 5, 2017.
- This option became fully exercisable on January 7, 2018.
- This option becomes fully exercisable on January 7, 2019.
- This option becomes fully exercisable on January 6, 2020.
- This option becomes fully exercisable on January 5, 2021.
- This option becomes fully exercisable on January 4, 2022.
- This option becomes fully exercisable on January 3, 2023.
Billionaire Hedge Funds
